WeVote
Log In

Bill

Bill

HB 2349

To offer long-acting reversible contraception to patients receiving methadone and suboxone at the treatment facility for the methadone and suboxone

2025 Regular Session Introduced by Michael Amos and 10 co-sponsors

HB 2349 mandates opioid treatment programs to provide long-acting reversible contraception, enhancing reproductive health for patients on methadone and suboxone.

Laid over on 3rd reading 4/11/2025
#health
0
WeVote Research Nonpartisan
Bill Summary · HB 2349

Summary of HB 2349

Bill Number: HB 2349
Title: To offer long-acting reversible contraception to patients receiving methadone and suboxone at the treatment facility for the methadone and suboxone
Status: Laid over on 3rd reading on April 11, 2025
Introduced: January 30, 2025
Classification: Bill
Subject: Health

Purpose and Intent

HB 2349 aims to enhance reproductive health services for individuals undergoing treatment for opioid addiction, specifically those receiving methadone and suboxone. The bill mandates that opioid treatment programs (OTPs) offer long-acting reversible contraception (LARC) to their patients, thereby addressing the intersection of substance use treatment and reproductive health.

Key Provisions

  • Contraceptive Offerings: The bill requires OTPs to provide access to long-acting reversible contraception, such as IUDs and implants, to patients recovering from addiction.

  • Counseling Requirements:

    • OTPs must offer shared decision-making contraceptive counseling that is non-coercive and tailored to each patient's lifestyle and health needs.
    • Counseling services must be available for both male and female patients.
    • Medical eligibility screenings for potential contraindications are mandated.

  • Medical Assessment and Referral Process:

    • OTPs must have qualified providers on staff who are trained to place or insert LARC.
    • If an OTP lacks the necessary medical personnel or equipment, they must establish a referral system to direct patients to licensed healthcare providers or clinics that can provide full contraceptive services.

Affected Parties

  • Patients: Individuals receiving methadone and suboxone treatment will benefit from improved access to reproductive health services.
  • Opioid Treatment Programs: OTPs will be required to implement new protocols for contraceptive counseling and provision, which may involve additional training and resources.

Procedural Aspects

  • Legislative Timeline:
    • The bill was introduced on January 30, 2025, and has undergone several readings and amendments.
    • It was reported do pass with title amendments on April 9, 2025, and passed the House on March 21, 2025.
    • The bill is currently laid over on the 3rd reading as of April 11, 2025, indicating that further discussion or action may be pending.

Conclusion

HB 2349 represents a significant step towards integrating reproductive health services into opioid addiction treatment programs. By ensuring that patients have access to long-acting reversible contraception, the bill seeks to empower individuals in their reproductive choices while undergoing treatment for substance use disorders.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.